Concert Pharmaceuticals is a clinical-stage biopharmaceutical company focused on applying its DCE Platform® (deuterated chemical entity platform) to create novel medicines designed to address unmet patient needs.

Biotechnology

Pharmaceutical

Concert Pharmaceuticals

Roger D. Tung

Karen Merrill

Kristine Hogan

Bob Zelle

Ken Goldenberg (Mitch)

Christopher L. Brummel

Nabil Uddin

Jeffrey A. Munsie

K. Mitch Goldenberg

Cameron J. Cowden

Christine Boisclair

Justine E. Koenigsberg

James V. Cassella

Nancy Stuart

The Research and Development team at Concert Pharmaceuticals is dedicated to advancing the company's drug portfolio by leveraging the DCE Platform® to create innovative therapies. This multidisciplinary team collaborates on pharmaceutical development, clinical operations, regulatory affairs, and quality assurance to ensure the successful progression of drug candidates from conception through clinical trials, ultimately addressing critical unmet medical needs.

Research and Development

Leadership Team

Research and Development

About

Team members

Other teams at Concert Pharmaceuticals

Leadership Team